PLK2 and Parkinson disease: Although the mechanism of the neuroprotective effect of PLK2 KO is yet to be determined, our work suggests that the development of PLK2-specific small-molecule inhibitors, several of which have already been produced (31), is a potentially promising strategy for slowing neurodegeneration in PD and DLB.